Cutaneous Oncology News

In addition to cutting edge content, the 22nd annual South Beach Symposium has added a “unique session” that focuses on how the medical and cosmetic dermatologist can work together to holistically treat patients.

Intralesional immunotherapy shows potential as a treatment for cutaneous malignancies, including nonmelanoma skin cancer, according to a speaker at this year’s ODAC Dermatology, Aesthetic & Surgical Conference.

Evaluating the loss of life expectancy among patients diagnosed with cutaneous melanoma may help establish a lifetime prognosis for patients, according to a study.

Black patients experience higher acral melanoma rates, as well as melanoma-associated mortality rates, compared with white patients, according to a study.

Metabolic changes can be identified in patients with advanced melanoma by imaging tumors within 1 week of beginning immunotherapy, according to a study published in Clinical Cancer Research.

In patients with Fitzpatrick skin types IV through VI, gene expression analysis can help rule out melanoma, according to a poster presented at the Winter Clinical Dermatology Conference.

Non-Hispanic American Indian and Alaskan Native populations exhibited increasing rates of melanoma over the span of two decades, especially in certain parts of the country, according to a study.

The phase 2 clinical trial of Verrica’s peptide-based immunotherapy trial for basal cell carcinoma has enrolled and dosed its final patient, the company announced in a press release.

Many patients with early onset Merkel cell carcinoma have genetic variants leading to possible increased cancer risks and should receive genetic counseling and testing, according to a study.

Minimally invasive, nonsurgical local treatments could be a possible option for small cutaneous neurofibromas instead of surgical removal, according to a study.